Tissue Transglutaminase Ab Screen ELISA Kit

  • Created on the 29 June, 2017.


Human tissue transglutaminase screen ELISA kit is intended for simultaneous in-vitro quantitative analysis of IgA and IgG auto-antibodies to tissue transglutaminase (tTG screen) in human plasma and serum samples. This assay has a minimum analytical sensitivity limit of 1.0 U/ml.


Tissue transglutaminase antibodies (tTG-IgA and tTG-IgG) can be very useful marker to screen for celiac disease. This is due to the fact that individuals with celiac disease eat a gluten diet which contains higher levels of particular antibodies within their blood.  tTG (IgA and IgG) antibodies are produced since it views gluten as a treat, 98% of patients with celiac disease will display a positive test for tTG-IgA who are on a gluten-containing diet. However, some coeliac disease individuals are unable to produce the coeliac disease antibodies (known as IgA deficiency), in this case it is recommended to perform the following tests IgG deamidated gliadin peptide (DGP), immunoglobulin G (IgG) EMA and IgG-tTG. There is also a slight risk of obtaining a false positive test result, if people have other associated autoimmune disorders such as rheumatoid arthritis, autoimmune liver disease, Hashimoto’s thyroiditis, type 1 diabetes, heart failure but who do not have celiac disease. The following tissue transglutaminase screen ELISA kit can be used in various diagnostic applications.


The minimum detection sensitivity level of tTG IgA/IgG class auto-antibodies (tTG screen) using current human tissue transglutaminase screen ELISA kit was 1.0 U/ml. The dynamic range for this assay is 5.0 – 200.0 U/ml.


  1. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening. J Pediatr Gastroenterol Nutr. (2015) 60 (6): 787-91. Webb C., et al.
  2. Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children. Clin Chim Acta. (2015) 446: 237-40. Frulio G., et al.
  3. Development of a mechanism-based assay for tissue transglutaminase–results of a high-throughput screen and discovery of inhibitors. Anal Biochem. (2005) 338 (2): 237-44. Case A., et al.
  4. Tissue transglutaminase-serology markers for coeliac disease. Clin Chem Lab Med. (2002) 40 (5): 485-92. Kocna P., et al.
  5. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics. (2001) 107 (1): E8. Chan A.W., et al.


  • Full Name: Tissue Transglutaminase Ab Screen ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: 1.0 U/ml



Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford